JPRN-UMIN000004072招募中2 期
Early induction of docetaxel for castration resistance prostate cancer - PC-DOC
M-CURE0 个研究点目标入组 65 人开始时间: 2010年8月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)active infection 2)fever over 38 cent degree 3)allergy with docetaxel or steroid 4)physician deny the entry
研究者
相似试验
尚未招募
3 期
Gabapentin for taxane associated acute pain syndrome - randomised, placebo-controlled, crossover trial. The TAPS TrialTaxane associated acute pain syndromeCancer - BreastBreast cancerACTRN12611000666921Sunshine Coast Cancer Centre, Nambour General Hospital126
已完成
2 期
preoperative combined chemothrapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer; multicentric phase II studylocal advanced gastric cancer (excluding T3-4, bulky N2 &N3 and giant type3 &type 4)JPRN-UMIN000002081Society for the study of DCS therapy55
进行中（未招募）
1 期
First Line Dose-Dense Chemotherapy With Docetaxel, Cisplatin, Folinic Acid and 5- Fluorouracil plus Panitumumab in Patients With Locally Advanced or Metastatic Cancer of the Stomach or Gastro-Esophageal Junction: A Phase II Multicentre Trial - GOIRC 02/2009Patients with metastatic or locally advanced not resectable cancer of the stomach or gastro-esophageal junction.MedDRA version: 9.1Level: PTClassification code 10017758MedDRA version: 9.1Level: HLTClassification code 10030176EUCTR2009-016962-10-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA52
已完成
2 期
Multicenter phase II trial to Prevent Docetaxel-Induced Nail change using a Frozen Glove with docetaxel (T) and cyclophosphamide(C) as adjuvant chemotherapy for patients with high risk, node negative, early stage breast cancer: Tokai Breast Cancer Clinical Research Group (TBCRG) 03 trialBreast cancerJPRN-UMIN000000806Tokai Breast Cancer Clinical Research Group (TBCRG)50
已完成
不适用
Docetaxel plus cyclophophamide as adjuvant chemotherapy for negative axillary lymph node breast cancerBreast CancerJPRN-UMIN000001076Kinki Multidisciplinary Breast Oncology Group35